Background/objectives: Laryngeal paragangliomas are benign slow growing tumors with symptoms resembling squamous cell carcinoma. Hoarseness or dysphasia is the commonest presenting symptom and usually it presents as a submucosal mass on laryngoscopy. A total of 90% of these tumors occur in the supraglottic larynx and the rest in the glottis and the subglottic region. Functional activity is seen in a few (2.9%), none are associated with paraneoplastic syndromes.
INTRODUCTION
Head and neck paragangliomas are rare tumors arising from the neural crest.
1,2 They are highly vascularized tumors involving the walls of the blood vessels or specific nerves. [3] [4] [5] In the larynx, they arise from superior or inferior laryngeal paraganglia and are seen in the supraglottis in 90% of the cases. 6 Since these tumors are from neural crest-derived cells of the parasympathetic nervous system, they usually appear adjacent to nerve structures, most commonly the superior laryngeal nerve or the recurrent laryngeal nerve. 7 The paragangliomas of the larynx show a female preponderance compared to other neuroendocrine tumors. 6 Other neuroendocrine tumors differ in their biologic behavior, management and prognosis compared to paragangliomas and so immunohistochemical differentiation forms an important criteria. 8 Paragangliomas of larynx are benign submucosal lesion and the management includes a conservative resection. 6 Significant intraoperative blood loss is expected so preoperative transarterial embolization has proved beneficial. 9, 10 Percutaneous direct intratumoral embolization can also be done with same efficacy. [11] [12] [13] [14] Supraglottic laryngectomy and lateral pharyngotomy are commonly used approaches for managing these paragangliomas.
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CASE REPORT
A 35-year-old male presented to us with hoarseness of voice since 4 months duration. There was no history of difficulty in swallowing and any other symptoms. Also on examination, a swelling in left side of the neck was seen confirmed on palpation. Indirect laryngoscopic examination revealed a congested globular flashy mass arising from the left pharyngoepiglottic fold, extending to the aryepiglottic fold and to the apex of the pyriform fossa with mobile vocal cords. The patient was a nonsmoker and nondrinker also; complained of foreign body sensation. Contrast-enhanced computed tomographic (CT) scan was done and an enhancing lesion was seen in the same region with radiological features suggesting of a vascular lesion or a paraganglioma (Fig. 1) . Translaryngeal fine needle aspiration cytology revealed cells similar to that of paraganglioma, but a vascular malformation and schwannomas were not ruled out. His blood investigations and urine catecholamine levels were normal. Magnetic resonance angiography revealed a 3 to 4 cm vascular lesion in the left supraglottic region but the feeder vessels were not found. So, a digital subtraction angiography (DSA) done revealed the superior thyroid artery to be the feeder and a minor contribution from contralateral superior thyroid was seen. DSA demonstrated that the left superior thyroid artery supplied greater than 80% of the blood supply to the laryngeal mass (Fig. 2) . Superselective embolization was done from the right femoral under local anesthesia and sedation which was uneventful. Left superior thyroid artery was selectively catheterized using the 4F vertebral glide catheter over the 0.035 Terumo guide wire and embolized using 510 to 750 sized polyvinyl alcohol (PVA) particles. A minimal tumor blush was noted after this and the feeders were embolized using a microguide wire with 250 to 500 PVA particles. Finally, after embolization, partial tumor blush was seen with feeders from the proximal part of the left superior thyroid artery. Since these feeders were close to origin of external carotid artery, no attempt was made to block these feeders. There was no other neurological deficit noticed after embolization.
Direct laryngoscopic evaluation was done in 48 hours and the pulsatile vascular lesion was assessed and approached from a lateral pharyngotomy incision. An elective tracheostomy was done to secure the patient's airway before lateral pharyngotomy with minimal blood loss. Intraoperatively, the larynx was approached and the thyroid ala dissected and left superior thyroid artery was ligated and cut along with the superior laryngeal nerve. The subglottis was normal, as was the base of the tongue and pharynx (Fig. 3 ).
Later the thyroid cartilage was dissected and the tumor was excised. He was extubated with the postoperative period being uneventful. Histopathology revealed features suggestive of paraganglioma and all the lymph nodes had reactive changes. Microscopic examination showed polygonal epithelioid cells arranged in discrete nests (Zellballen pattern). Immunohistochemistry results showed that the neoplastic cells were positive for chromogranin, synaptophysin and S-100 but negative for CK and epithelial membrane antigen (EMA). So, all these features were consistent with paraganglioma.
DISCUSSION
Laryngeal paraganglioma was first described in 1955 and since then 85 cases were described in world literature. 8 Ferlito et al analyzed all the reported paragangliomas of the larynx and found that 62 case reports genuinely met the criteria for diagnosis. 2, 8, 16 These are benign slow growing tumors with symptoms resembling squamous cell carcinoma. 8 Hoarseness or dysphasia are the commonest presenting symptoms and usually it presents as a submucosal mass on laryngoscopy. 8 Rarely stridor, dysphagia, foreign body sensation and dyspnea are seen and depends on the size and location of the tumor. 16 The majority of these tumors arise in the supraglottic larynx, and 2% of these are malignant.
2,8,16
A histological diagnosis is necessary prior to surgical treatment and repetitive fine needle aspiration biopsies are Differentiating laryngeal paragangliomas from carcinoids, atypical carcinoids and other neuroendocrine carcinoma on microscopic examination is not impossible and immunohistochemistry is helpful. 22 The chief cells are immunoreactive to neuroendocrine markers chromogranin, synaptophysin and neuron-specific enolase and negative for epithelial markers including cytokeratin. 1, 20 Atypical carcinoids of the larynx show immunoreactivity for both neuroendocrine markers and epithelial markers. 6 The sustentacular cells are immunoreactive to S-100, but chief cells are negative for melanoma markers S-100, HMB45 and melan-A, excluding this from melanoma. 23 Non-neuroendocrine tumors are excluded by chromogranin positivity and the absence of keratin positivity and presence of S-100 protein-positive sustentacular cells tends to exclude carcinomas. 24 These tumors can be confused on microscopy as carcinoid tumor, malignant melanoma, medullary thyroid carcinoma and small-cell neuroendocrine carcinoma. 24 S-100 testing is particularly necessary to establish the correct diagnosis as its negative in typical and atypical carcinoid and small-cell neuroendocrine carcinoma. 25 Cytokeratin, epithelial membrane antigen, carcinoembryonic antigen are negative in paragangliomas while positive in carcinoids and small-cell neuroendocrine carcinoma. 25 Chromogranin, synaptophysin, neuronspecific enolase are positive in all the laryngeal neuroendocrine tumors. 25 Galanin, glial fibrillary acidic protein are very specific for laryngeal paragangliomas. 25 The mutations in the SHDB, SDHC and SHDD genes reflect higher risk for developing malignant paragangliomas, whereas VHL and NF1 genes mutation reflect inherited paragangliomas. 26, 27 Rare cases of laryngeal paraganglioma associated with multicentric head and neck paraganglioma syndrome are also reported. 28 A total of 90% of these tumors occur in the supraglottic larynx and the rest in the glottis and the subglottic region. Functional activity is seen in a few (2.9%), none are associated with paraneoplastic syndromes. 1, 19 They spread by vocal fold fixation and rarely associated with necrosis and vascular invasion. 1, 19 Some herniate through the thyrohyoid membrane and present as a neck mass. 29 If imaging provide sufficient evidence of probable diagnosis of paraganglioma (or any other vascular tumor), then a biopsy can be omitted and direct surgery following angiography and embolization seems better. 5 Some tumors may be large enough to herniate through the thyrohyoid membrane and present as a neck mass.
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Contrast-enhanced computerized tomography (CECT neck) and contrast-enhanced magnetic resonance imaging (MRI) rules out less enhancing laryngeal masses. 15 MRI is also useful in detecting lesions that are smaller than 5 mm and to screen for synchronous paragangliomas.
30,31
Contrast-enhanced MRI angiography (MRA) does not increase the diagnostic value of MRI but defines the vascularity of the tumor. 32 DSA is more sensitive in detecting vascularization compared to MRA. 10, 33 Also tumors larger than 2.5 cm, four vessel angiography and preoperative embolization is useful in minimizing bleeding and injury to surrounding neurovascular structures. 10, 33 DSA also allows the determination of carotid artery invasion and the performance of balloon occlusion studies to assess collateral cerebral circulation in carotid body paragangliomas. 10, 33 Usually superior thyroid artery is the primary vessel that supplies these tumors, so embolization creates a bloodless surgical field. 34 Preoperative embolization done by superselective catheterization of the supplying branches and transarterial embolization with particulate agents dramatically improves the operative field. 35 Sonography-guided or CT-guided intratumoral injection of a liquid adhesive like N-butyl-2-cyanoacrylate (NBCA) gives better devascularization compared to transarterial embolization and is a safe and effective method of preoperative embolization. [11] [12] [13] [14] Percutaneous direct embolization provides an easy access to hypervascular tumor with a higher chance of achieving complete devascularization.
12,36 Direct embolization is typically carried out with NBCA.
12,36
Percutaneous tumor embolization is easy and safe but complications of glue migration into the intracranial circulation is a fatal complication. 12, 36 Casasco et al advocated the use of nondetachable balloons to protect the intracranial branches to reduce the risk of glue reflux into the circulation. 12, 36 No other complications are reported in the procedure. 12, 36 Most of the laryngeal paragangliomas are managed surgically and organ preservation partial laryngectomy procedures are becoming the standard protocol. 1, 6 Radical surgeries are not indicated as regional and distant metastasis are rarely documented. 1, 6 Transoral resections are not advised because hemostasis management can prove fatal, so lateral pharyngotomy is preferred depending on the extent and site of the tumor. 1, 6 The endoscopic approach provides limited exposure and access to the lesion. 6 This is not a good approach for vascular tumors, because hemorrhage might obscure visualization of tissue planes. 6 The biological behavior of the tumor is not extensively defined as the tumor is rare and the malignant potential hardly exist. 37 All these lesions are treated by surgical resection which includes supraglottic or total laryngectomy and endoscopic resection. 18, 37 Inferior laryngeal paragangliomas present in the subglottis having dyspnea and shortness of breath and need careful consideration for airway management preoperatively. 18, 37 Most of them were managed by total laryngectomy as the primary treatment. 18, 37 Lateral pharyngotomy approach is described for removal of supraglottic submucosal tumors, including paraganglioma. 17 All procedures are aimed at complete tumor removal with minimum functional deficits. 17 This approach can be performed without a tracheostomy for smaller lesions, but for resection of vascular masses, a tracheotomy should be performed. 6 Also conservation laryngeal approaches are not attempted when cartilage involvement is seen radiographically. 18, 37 Submucosal resection with meticulous dissection results in no postoperative dysphagia and excellent voice preservation. 6 Laryngeal paragangliomas are benign tumors and presence of vascular, capsular or perineural invasion, focal necrosis, mitoses does not indicate metastatic potential. 38, 39 Malignant paragangliomas are reported in 2% in some series, while pathologic findings cannot predict clinical and biological behavior of the tumor. 1, 2, 34 Rare cases of distant metastasis are reported, while neck nodes spread are rarely reported and so selective neck node clearance is not warranted. 1,2 Regular follow-up is advised as not much literature on the biological behavior of the tumor is known. 38, 39 A recurrence rates of 17% is reported in superior laryngeal paragangliomas and 4% in inferior laryngeal paraganglioma with careful follow-up should be given to the inferior laryngeal cases due to the potential for rapid airway obstruction with recurrent or persistent disease. 18, 37 Local recurrence may be a sign of malignancy. 18, 37 No role of radiotherapy or chemotherapy is used as a laryngeal preservation approach. 5 In cervical paragangliomas, external beam radiation provides approximately 90% tumor control rate. 5 Ferlito et al suggested the existence of other atypical carcinoid tumors as high as 25% which were earlier thought as metastasis.
1,2,34 They reviewed 65 cases over 35 years and found the mean age to be 44 years, mean duration of symptoms to be 26 months and most of the tumors were excised surgically. 1,2,34 They reported no role of radiation or chemotherapy.
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CONCLUSION
Early diagnosis of these laryngeal paragangliomas is difficult as they present with nonspecific clinical manifestation. Complete surgical resection or partial laryngectomy with meticulous dissection of surrounding tissues and preservation of neurovascular structures gives an excellent prognosis as far as oncological clearance is concerned. Malignant paragangliomas of the larynx are rare and a major meta-analysis is necessary to provide a true biological behavior of this tumor.
